Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Follow-Up Questions
¿Quién es el CEO de Novo Integrated Sciences Inc?
Mr. Robert Mattacchione es el Chairman of the Board de Novo Integrated Sciences Inc, se unió a la empresa desde 2018.
¿Qué tal es el rendimiento del precio de la acción NVOS?
El precio actual de NVOS es de $0.06, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Novo Integrated Sciences Inc?
Novo Integrated Sciences Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Novo Integrated Sciences Inc?
La capitalización bursátil actual de Novo Integrated Sciences Inc es $1.1M
